Oura IPO Puts Spotlight on Largest Medical Device and HealthTech Stocks
Oura's $2.2 billion IPO is framed as a milestone for wearable health technology, shifting the smart-ring maker toward a biometric data platform with subscription revenue. The article ranks the ten largest medical devices and healthtech companies by market value, with Johnson & Johnson at $663.2 billion ahead of Abbott, Danaher, Intuitive Surgical, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences, Becton Dickinson, and Agilent. It also provides one-month, three-month, and year-to-date performance plus relative-strength rankings for those leaders.
Oura’s $2.2 billion IPO highlights wearable health technology. The smart-ring maker is shifting from a consumer wellness device toward a biometric data business supported by subscriptions.
The article ranks the ten largest medical device and healthtech companies by market value. Johnson & Johnson leads at $663.2 billion, ahead of Abbott, Danaher, Intuitive Surgical, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences, Becton Dickinson, and Agilent. It also compares one-month, three-month, and year-to-date returns and relative strength. The theme contains 227 stocks and was down 3.1% over one month as of September 24, 2026.
The Oura IPO may increase attention and capital for wearable health technology, potentially speeding devices that track sleep, recovery, and other biometrics. Consumers and patients could gain more continuous health insights, while clinicians may receive new data streams. Investors, employers, and insurers might explore subscription-based monitoring. Growth could also raise questions about privacy, accuracy, and equitable access.